Transcranial Magnetic Stimulation (TMS) to Treat Depression in Autism Spectrum Disorder
RecruitingNCT06142955Phase: NAStarted 2024-04-30
Summary
This study will assess clinical and behavioral measures along with electroencephalogram (EEG), event-related potentials (ERPS), and eye-tracking (ET) prior to and following a single intermittent Theta
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
40 Years
Locations
Yale Psychiatric HospitalNew Haven, Connecticut, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06142955